К содержанию
РецензированоEN2025

EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS

S.M. Muhammadieva (Tashkent Medical Academy) · Z.T. Abdusolieva (Tashkent Medical Academy) · D.D. Nabidzhonova (Tashkent Medical Academy)

Академические исследования в современной науке · 70-72 · 2025

Аннотация

The purpose of our study was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR criteria under the influence of synthetic disease-modifying drugs or biological agents.

Доказательный фрагмент

«The purpose of our study was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR…»

Образец извлечения

Демо-превью

The purpose of our study was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR… Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Тип
Журнал
Страна
Узбекистан
Ключевые слова
purpose, our, evaluate, efficacy, safety, baricitinib, patients
Спросить CiteX об этой работе

Смежные источники